Literature DB >> 3605061

Epidemiologic programs for computers and calculators. Inferences on odds ratios, relative risks, and risk differences based on standard regression programs.

S Wallenstein, C Bodian.   

Abstract

Statistical analyses of the joint effects of several factors (covariates) on the risk of disease, death, or other dichotomous outcomes, are frequently based on a model that relates the effect of the covariates to some function of the probability of the outcome. The odds ratio, relative risk, and the difference in risks are among the simplest candidates for the outcome function. Each can be specified as a special case of the generalized linear model, but their use has been limited to researchers with access to specialized computer programs that are not yet generally available in standard computer packages. The purpose of this communication is to describe how to implement the maximum likelihood estimation procedures and hypothesis testing associated with the generalized linear model using any computer program that can perform weighted least squares analyses. The procedure is applied specifically to models for relative risks, risk differences, and odds ratios. The techniques are illustrated with SAS and SPSSx programs for data sets previously presented.

Entities:  

Mesh:

Year:  1987        PMID: 3605061     DOI: 10.1093/aje/126.2.346

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  2 in total

1.  Outcomes, safety, and resource utilization in a collaborative care birth center program compared with traditional physician-based perinatal care.

Authors:  Debra J Jackson; Janet M Lang; William H Swartz; Theodore G Ganiats; Judith Fullerton; Jeffrey Ecker; Uyensa Nguyen
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  Sample size estimation for modified Poisson analysis of cluster randomized trials with a binary outcome.

Authors:  Fan Li; Guangyu Tong
Journal:  Stat Methods Med Res       Date:  2021-04-07       Impact factor: 2.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.